I’m pretty sure it’s because, as the article mentioned, it’s still a Schedule 1 drug which carries with it major restrictions on use for medical research. These big official companies can’t really do the research as long as it’s Schedule 1.
I’m pretty sure it’s because, as the article mentioned, it’s still a Schedule 1 drug which carries with it major restrictions on use for medical research. These big official companies can’t really do the research as long as it’s Schedule 1.